TRML

Tourmaline Bio (TRML)

Tourmaline Bio Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:TRML

1 2 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/23	20 : 10	GlobeNewswire Inc.	Tourmaline Bio to Present at the Jefferies Global Healthcare Conference	NASDAQ:TRML	Tourmaline Bio Inc
2024/05/16	20 : 00	GlobeNewswire Inc.	Tourmaline Bio Initiates Clinical Development of TOUR006 for Cardiovascular Diseases with First Patient Dosed in Phase 2 TRANQUILITY Trial	NASDAQ:TRML	Tourmaline Bio Inc
2024/05/14	05 : 18	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:TRML	Tourmaline Bio Inc
2024/05/13	20 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TRML	Tourmaline Bio Inc
2024/05/13	20 : 00	GlobeNewswire Inc.	Tourmaline Bio Reports First Quarter 2024 Financial Results and Recent Business Highlights	NASDAQ:TRML	Tourmaline Bio Inc
2024/04/02	20 : 00	GlobeNewswire Inc.	Avalo Therapeutics Appoints Biotech Leaders to Board of Directors	NASDAQ:TRML	Tourmaline Bio Inc
2024/03/19	20 : 00	GlobeNewswire Inc.	Tourmaline Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights	NASDAQ:TRML	Tourmaline Bio Inc
2024/02/27	21 : 30	GlobeNewswire Inc.	Tourmaline Bio to Present at Upcoming Investor Conferences	NASDAQ:TRML	Tourmaline Bio Inc
2024/02/15	11 : 08	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:TRML	Tourmaline Bio Inc
2024/02/15	10 : 51	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:TRML	Tourmaline Bio Inc
2024/02/10	06 : 22	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:TRML	Tourmaline Bio Inc
2024/02/01	22 : 00	GlobeNewswire Inc.	Tourmaline Bio to Present at the Guggenheim Healthcare Talks \| 6th Annual Biotechnology Conference	NASDAQ:TRML	Tourmaline Bio Inc
2024/01/30	06 : 01	GlobeNewswire Inc.	Tourmaline Bio Announces Closing of $172.5 Million Public Offering of Common Stock, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares	NASDAQ:TRML	Tourmaline Bio Inc
2024/01/27	06 : 12	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TRML	Tourmaline Bio Inc
2024/01/27	06 : 08	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:TRML	Tourmaline Bio Inc
2024/01/25	21 : 00	GlobeNewswire Inc.	Tourmaline Bio Announces Pricing of Public Offering of Common Stock	NASDAQ:TRML	Tourmaline Bio Inc
2024/01/25	11 : 20	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:TRML	Tourmaline Bio Inc
2024/01/25	07 : 10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TRML	Tourmaline Bio Inc
2024/01/25	06 : 05	GlobeNewswire Inc.	Tourmaline Bio Announces Proposed Public Offering of Common Stock	NASDAQ:TRML	Tourmaline Bio Inc
2024/01/08	23 : 19	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TRML	Tourmaline Bio Inc
2024/01/08	21 : 00	GlobeNewswire Inc.	Tourmaline Bio Announces Expected Upcoming Key Milestones for the Clinical Development of TOUR006, a Long-Acting Subcutaneous Inhibitor of IL-6 with Best-in-Class Potential, in Thyroid Eye Disease (TED) and Atherosclerotic Cardiovascular Disease (ASCVD)	NASDAQ:TRML	Tourmaline Bio Inc
2023/12/16	06 : 00	GlobeNewswire Inc.	Tourmaline Bio added to the NASDAQ Biotechnology Index	NASDAQ:TRML	Tourmaline Bio Inc
2023/12/14	22 : 27	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TRML	Tourmaline Bio Inc
2023/12/14	21 : 30	GlobeNewswire Inc.	Tourmaline Bio Appoints Dr. Clay Siegall as Chairman of the Board	NASDAQ:TRML	Tourmaline Bio Inc
2023/11/30	22 : 25	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TRML	Tourmaline Bio Inc
2023/11/01	21 : 00	GlobeNewswire Inc.	Tourmaline Bio to Present at Upcoming Investor Conferences	NASDAQ:TRML	Tourmaline Bio Inc
2023/10/24	09 : 33	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TRML	Tourmaline Bio Inc
2023/10/24	09 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TRML	Tourmaline Bio Inc
2023/10/24	09 : 25	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TRML	Tourmaline Bio Inc
2023/10/24	09 : 24	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TRML	Tourmaline Bio Inc